Author Page for Michel van den Heuvel

High Dose Osimertinib in Patients with Advanced Stage EGFR Exon 20 Mutation-Positive NSCLC: Results from the Phase 2 Multicenter POSITION20 Trial

Number of pages: 21 Posted: 25 Feb 2022

Fenneke Zwierenga, Bianca van Veggel, Lizza E.L. Hendriks, T.Jeroen N. Hiltermann, Birgitta I. Hiddinga, Lucie B.M. Hijmering – Kappelle, Arja ter Elst, Sayed M.S. Hashemi, A-M.C. Dingemans, Cor van der Leest, Adrianus J. de Langen, Michel van den Heuvel and Anthonie J. van der Wekken

University of Groningen - Department of Pulmonology, affiliation not provided to SSRN, Maastricht University, University of Groningen - Department of Pulmonary Diseases, affiliation not provided to SSRN, University of Groningen - University Medical Center Groningen, affiliation not provided to SSRN, affiliation not provided to SSRN, Erasmus University Rotterdam, Amphia Hospital, Netherlands Cancer Institute, Radboud University Nijmegen - Department of Pulmonary Diseases and University of Groningen - University Medical Center Groningen

Downloads 91

Abstract:

2.

Plasma Cells and Endothelitis in COVID-19 Lung Pathology

Number of pages: 39 Posted: 12 May 2020

Frank L. van de Veerdonk, Monika Looijen-Salamon, Michel van den Heuvel, Quirijn van der Mast, Catrien van der Meer, Shoko Vos, Sarah van Belle, Sanne Vermorgen, Johannes G. van der Hoeven, Mihai G. Netea and Katrien Grünberg

Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen - Department of Pathology, Radboud University Nijmegen - Department of Pulmonary Diseases, Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Rivierenland ziekenhuis - Department of Intensive Care, Radboud University Nijmegen - Department of Pathology, Radboud University Nijmegen - Department of Pathology, Radboud University Nijmegen - Department of Pathology, Radboud University Nijmegen - Department of Intensive Care, Radboud University Nijmegen - Radboud Institute for Molecular Life Sciences (RIMLS) and Radboud University Nijmegen - Department of Pathology

Downloads 67

Citation 2

Abstract:

3.

Upfront Resection of Locally-Advanced And/Or Cavitating Nsclc Followed by Chemoradiotherapy (and Adjuvant Systemic Treatment); Phase 1 Multicenter Study to Assess Treatment Feasibility and Safety (NVALT32/UPLAN-I Trial)

Number of pages: 28 Posted: 21 Mar 2023

P.J.M. Joosten, R.G. Luger, Vincent van der Noort, W.S.M.E. Theelen, M.C. de Jong, K. Monkhorst, Ad F.T.M. Verhagen, Michel van den Heuvel, A.C. Dingemans, A.P.W.M. Maat, L.E.L. Hendriks, Merlijn Hutteman, Anthonie J. van der Wekken, A.M. Slats, Egbert Smit and K.J. Hartemink

Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute - Department of Biometrics, Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute Antoni van Leeuwenhoek, Radboud University Nijmegen - Radboud University Medical Center, Radboud University Nijmegen - Department of Pulmonary Diseases, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), Maastricht University Medical Center, Leiden University - Leiden University Medical Center (LUMC), University of Groningen - University Medical Center Groningen, Leiden University - Leiden University Medical Center (LUMC), Netherlands Cancer Institute Antoni van Leeuwenhoek and Netherlands Cancer Institute Antoni van Leeuwenhoek

Downloads 64

Abstract:

4.

Prophylactic folinic acid prevents pemetrexed myelosuppression: a randomized trial toward safer treatment with chemotherapy in non-small cell lung cancer

Number of pages: 21 Posted: 26 Nov 2025

Ramon Contrucci, Rob ter Heine, Merel Tonn, Jeroen Diepstraten, Eric van Thiel, Charlotte van Kesteren, Michel van den Heuvel, Cor van der Leest and Nikki de Rouw

affiliation not provided to SSRN, Radboud University Nijmegen - Department of Pharmacy and Radboud Center for Infectious Diseases, Amphia Hospital, Amphia Hospital, Albert Schweitzer Hospital, Albert Schweitzer Hospital, Radboud University Nijmegen - Department of Pulmonary Diseases, Amphia Hospital and Amphia Hospital

Downloads 55

Michel van den Heuvel

Radboud University Nijmegen - Department of Pulmonary Diseases

4

277

2

Scholarly Papers (4)

High Dose Osimertinib in Patients with Advanced Stage EGFR Exon 20 Mutation-Positive NSCLC: Results from the Phase 2 Multicenter POSITION20 Trial

Abstract:

Plasma Cells and Endothelitis in COVID-19 Lung Pathology

Abstract:

Upfront Resection of Locally-Advanced And/Or Cavitating Nsclc Followed by Chemoradiotherapy (and Adjuvant Systemic Treatment); Phase 1 Multicenter Study to Assess Treatment Feasibility and Safety (NVALT32/UPLAN-I Trial)

Abstract:

Prophylactic folinic acid prevents pemetrexed myelosuppression: a randomized trial toward safer treatment with chemotherapy in non-small cell lung cancer

Abstract: